Exhibit 5.1
![LOGO](https://capedge.com/proxy/8-K/0001193125-20-050213/g897151dsp082a.jpg)
February 26, 2020
HCA Inc.
HCA Healthcare, Inc.
c/o HCA Healthcare, Inc.
One Park Plaza
Nashville, Tennessee 37203
Ladies and Gentlemen:
We have acted as special counsel to HCA Inc., a Delaware corporation (the “Company”), and HCA Healthcare Inc., a Delaware corporation (the “Parent Guarantor”), in connection with the Company’s offering pursuant to a registration statement on FormS-3 (No.333-226709), as amended as of its most recent effective date (February 11, 2020), insofar as it relates to the Securities (as defined below) (as determined for purposes of Rule 430B(f)(2) under the Securities Act of 1933, as amended (the “Securities Act”)) (as so amended, including the documents incorporated by reference therein but excluding Exhibit 25.1, the “Registration Statement”) and the prospectus, dated August 9, 2018, as supplemented by the prospectus supplement thereto, dated February 11, 2020 (together, the “Prospectus”), of $2,700,000,000 aggregate principal amount of 3.500% Senior Notes due 2030 (the “Notes”). The Notes were issued under an indenture dated as of August 1, 2011 (the “Base Indenture”), among the Company, the Parent Guarantor, Delaware Trust Company (as successor to Law Debenture Trust Company of New York), as trustee (the “Trustee”) and Deutsche Bank Trust Company Americas, as paying agent, registrar and transfer agent (the “Paying Agent”), as supplemented, with respect to the Notes, by the twenty-sixth supplemental indenture dated as of February 26, 2020 (the “Supplemental Indenture;” and the Base Indenture as supplemented by the Supplemental Indenture, the “Indenture”) among the Company, the Parent Guarantor, the Trustee and the Paying Agent.
In arriving at the opinions expressed below, we have reviewed the following documents:
| (a) | the Registration Statement; |
![LOGO](https://capedge.com/proxy/8-K/0001193125-20-050213/g897151dsp082b.jpg)